Sobi contributes to a sustainable future as part of our vision of becoming a global leader in providing access to innovative treatments that make a significant difference for individuals with rare diseases.

The Group’s overall objective from a sustainability perspective is tied to this overall vision: to contribute to the societies in which Sobi operates by improving access to treatment of rare diseases. A sustainable business entails a commitment to responsibility for patients and employees, reduced environmental impact from operations and treatment, as well as long-term sustainable profitability.

Sobi reports on its sustainability efforts within the framework of the Global Reporting Initiative (GRI) and applies GRI Standards: Core option.